| Intervention (n = 60) |  | Placebo control (n = 61) |  | ||
---|---|---|---|---|---|---|
Pre-test | Post-test | p | Pre-test | Post-test | p | |
VRSQ Total | 80.65 ± 10.01 | 46.23 ± 16.79 | < 0,001 | 78.54 ± 12.43 | 74.24 ± 13.69 | 0.067 |
VRSQ Oculomotor | 35.46 ± 4.83 | 21.15 ± 7.98 | < 0,001 | 34.57 ± 5.93 | 33.82 ± 6.17 | 0.494 |
VRSQ Discomfort | 45.18 ± 5.70 | 25.08 ± 8.93 | < 0,001 | 43.19 ± 6.71 | 41.15 ± 38.17 | 0.125 |
Tolerance (minute) | 8.13 ± 2.93 | 12.75 ± 2.64 | < 0,001 | 7.88 ± 2.58 | 8.73 ± 2.85 | 0.116 |
VAS (mm) | 28.58 ± 16.30 | 56.98 ± 22.09 | < 0,001 | 45.86 ± 19.77 | 54.29 ± 20.87 | 0.031 |
OSI | 0.45 ± 0.21 | 0.35 ± 0.28 | 0.043 | 0.50 ± 0.27 | 0.49 ± 0.26 | 0.561 |
FBT | 10.19 ± 1.50 | 9.51 ± 1.99 | 0,021 | 10.12 ± 2.57 | 9.85 ± 1.92 | 0.158 |